This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hookworm

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Hookworm can be contracted from eating contaminated food, or may penetrate the skin, e.g. soles of feet. They pass to the lungs and are coughed up and swallowed. The adult worm lives in the upper small intestine and releases eggs that pass out in the faeces.

Hookworms inhabit the small bowel and suck blood from their point of attachment. An iron deficiency anaemia often exists and this merits treatment along with the hookworms.

There are an estimated 900 million cases worldwide.

The most widely used drugs recommended by WHO are albendazole and mebendazole:

  • a systematic review revealed that the highest observed cure rate for hookworm was 80% from albendazole (1)
  • a study has shown superiority of emodepside (30mg) compared with albendazole (400mg), with observed cure rate of 96.6% vs 81.2% (2)

Reference:

  1. Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ. 2017 Sep 25;358:j4307.
  2. Taylor L et al. Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial. Lancet August 17th 2024.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.